Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 3/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18140497 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL8617504 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL18139924 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL18141661 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL18140754 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL18141348 | 0.91 | PTPN7 (0.48) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL6728251 | 0.85 | — | — | |
| SCHEMBL11309747 | 0.80 | HMGCR (0.38) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL4541833 | 0.80 | HMGCR (0.38) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL1109985 | 0.78 | HMGCR (0.36) | HMGCRPTPN7RECQLTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116134060-B | Method for producing aqueous dispersion of fluoroelastomer, and aqueous dispersion | 大金工业株式会社 | 2024-06-18 | — | — | CN | disclosed |
| CN-117529511-A | Method for producing aqueous dispersion of fluoroelastomer, composition, and aqueous dispersion | 大金工业株式会社 | 2024-02-06 | — | — | CN | disclosed |
| CN-117015557-A | Process for producing fluororesin, and aqueous dispersion | 大金工业株式会社 | 2023-11-07 | — | — | CN | disclosed |
| CN-116134060-A | Method for producing aqueous dispersion of fluoroelastomer, and aqueous dispersion | 大金工业株式会社 | 2023-05-16 | — | — | CN | disclosed |
| WO-2022030389-A1 | METHOD FOR PRODUCING AQUEOUS DISPERSION OF FLUORINE-CONTAINING ELASTOMER | ダイキン工業株式会社 | 2022-02-10 | — | — | WO | disclosed |
| WO-2022025188-A1 | METHOD FOR PRODUCING AQUEOUS DISPERSION LIQUID OF FLUORINE-CONTAINING ELASTOMER, FLUORINE-CONTAINING ELASTOMER AND AQUEOUS DISPERSION LIQUID | ダイキン工業株式会社 | 2022-02-03 | — | — | WO | disclosed |
| US-20180163056-A1 | HYDROPHILIC CURABLE COMPOSITIONS | MITSUI CHEMICALS, INC. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-20170209345-A1 | DENTAL PROSTHESIS | MITSUI CHEMICALS, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| EP-3081578-A1 | COMPOSITION FOR HYDROPHILIC CURED PRODUCT | Mitsui Chemicals, Inc. (JP) | 2016-10-19 | — | — | EP | disclosed |
| EP-2280009-A1 | NITROGENOUS HETEROCYCLIC COMPOUNDS AND FUNGICIDES FOR AGRICULTURAL AND HORTICULTURAL USE | Nippon Soda Co., Ltd. (JP) | 2011-02-02 | — | — | EP | disclosed |
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6737544-B1 | HEATING ABOVE MELTING POINT | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-18 | — | — | US | disclosed |
| EP-1393708-A1 | METHOD OF TREATING HAIR | Kao Corporation (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040011373-A1 | Method of treating hair | KAO CORPORATION (JP) | 2004-01-22 | — | — | US | disclosed |
| US-6150303-A | Substituted 3-phenylisoxazolines | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | CBR1, CBR3, QSOX1 | HMGCR 1622/4885PTPN7 2614/4885RECQL 763/4885 |
| US-20170209345-A1 | DENTAL PROSTHESIS | CAD, OR10J3, PSMA3 | HMGCR 2520/4885PTPN7 4023/4885RECQL 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.